Janney Montgomery Scott’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$492K Buy
28,743
+15,882
+123% +$272K ﹤0.01% 2013
2025
Q1
$821K Buy
+12,861
New +$821K ﹤0.01% 1669
2024
Q3
Sell
-1,388
Closed -$219K 2837
2024
Q2
$219K Buy
+1,388
New +$219K ﹤0.01% 2400
2023
Q4
Sell
-22,584
Closed -$2.74M 2749
2023
Q3
$2.74M Buy
22,584
+20,566
+1,019% +$2.49M 0.01% 901
2023
Q2
$231K Sell
2,018
-183
-8% -$20.9K ﹤0.01% 2382
2023
Q1
$303K Sell
2,201
-1,548
-41% -$213K ﹤0.01% 2044
2022
Q4
$486K Buy
+3,749
New +$486K ﹤0.01% 1793
2022
Q2
Sell
-3,253
Closed -$254K 2436
2022
Q1
$254K Sell
3,253
-161
-5% -$12.6K ﹤0.01% 1972
2021
Q4
$307K Buy
3,414
+638
+23% +$57.4K ﹤0.01% 1985
2021
Q3
$257K Sell
2,776
-1,558
-36% -$144K ﹤0.01% 2042
2021
Q2
$337K Buy
4,334
+380
+10% +$29.5K ﹤0.01% 1853
2021
Q1
$295K Sell
3,954
-511
-11% -$38.1K ﹤0.01% 1862
2020
Q4
$761K Sell
4,465
-333
-7% -$56.8K ﹤0.01% 1323
2020
Q3
$674K Sell
4,798
-163
-3% -$22.9K ﹤0.01% 1283
2020
Q2
$795K Buy
4,961
+117
+2% +$18.7K 0.01% 1152
2020
Q1
$474K Sell
4,844
-468
-9% -$45.8K ﹤0.01% 1248
2019
Q4
$685K Buy
5,312
+382
+8% +$49.3K ﹤0.01% 1271
2019
Q3
$371K Buy
4,930
+852
+21% +$64.1K ﹤0.01% 1561
2019
Q2
$620K Buy
4,078
+109
+3% +$16.6K ﹤0.01% 1305
2019
Q1
$473K Buy
3,969
+1,302
+49% +$155K ﹤0.01% 1424
2018
Q4
$291K Sell
2,667
-410
-13% -$44.7K ﹤0.01% 1577
2018
Q3
$497K Buy
3,077
+225
+8% +$36.3K ﹤0.01% 1454
2018
Q2
$377K Sell
2,852
-4,068
-59% -$538K ﹤0.01% 1538
2018
Q1
$513K Sell
6,920
-9,587
-58% -$711K 0.01% 1321
2017
Q4
$918K Buy
16,507
+6,062
+58% +$337K 0.01% 984
2017
Q3
$474K Buy
+10,445
New +$474K 0.01% 1285
2017
Q1
Sell
-16,246
Closed -$446K 1799
2016
Q4
$446K Buy
+16,246
New +$446K 0.01% 1131